Longitudinal trajectories of blood lipid levels in an ageing population sample of Russian Western-Siberian urban population
Language English Country United States Media electronic-ecollection
Document type Journal Article
Grant support
WT064947
Wellcome Trust - United Kingdom
WT081081
Wellcome Trust - United Kingdom
FS/18/23/33512
British Heart Foundation - United Kingdom
Medical Research Council - United Kingdom
Department of Health - United Kingdom
PubMed
34855783
PubMed Central
PMC8638938
DOI
10.1371/journal.pone.0260229
PII: PONE-D-21-21255
Knihovny.cz E-resources
- MeSH
- Cholesterol, HDL blood MeSH
- Smoking blood epidemiology MeSH
- Cholesterol, LDL blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Lipids * blood MeSH
- Longitudinal Studies MeSH
- Urban Population MeSH
- Aged MeSH
- Aging * blood MeSH
- Triglycerides blood MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Russia epidemiology MeSH
- Names of Substances
- Cholesterol, HDL MeSH
- Cholesterol, LDL MeSH
- Lipids * MeSH
- Triglycerides MeSH
This study investigated 12-year blood lipid trajectories and whether these trajectories are modified by smoking and lipid lowering treatment in older Russians. To do so, we analysed data on 9,218 Russian West-Siberian Caucasians aged 45-69 years at baseline participating in the international HAPIEE cohort study. Mixed-effect multilevel models were used to estimate individual level lipid trajectories across the baseline and two follow-up examinations (16,445 separate measurements over 12 years). In all age groups, we observed a reduction in serum total cholesterol (TC), LDL-C and non-HDL-C over time even after adjusting for sex, statin treatment, hypertension, diabetes, social factors and mortality (P<0.01). In contrast, serum triglyceride (TG) values increased over time in younger age groups, reached a plateau and decreased in older age groups (> 60 years at baseline). In smokers, TC, LDL-C, non-HDL-C and TG decreased less markedly than in non-smokers, while HDL-C decreased more rapidly while the LDL-C/HDL-C ratio increased. In subjects treated with lipid-lowering drugs, TC, LDL-C and non-HDL-C decreased more markedly and HDL-C less markedly than in untreated subjects while TG and LDL-C/HDL-C remained stable or increased in treatment naïve subjects. We conclude, that in this ageing population we observed marked changes in blood lipids over a 12 year follow up, with decreasing trajectories of TC, LDL-C and non-HDL-C and mixed trajectories of TG. The findings suggest that monitoring of age-related trajectories in blood lipids may improve prediction of CVD risk beyond single measurements.
3rd Department on Internal Medicine 1st Faculty of Medicine Charles University Prague Czech Republic
Department of Epidemiology and Public Health University College London London United Kingdom
Experimental Medicine Centre Institute for Clinical and Experimental Medicine Prague Czech Republic
Nuffield Department of Population Health University of Oxford Oxford United Kingdom
See more in PubMed
Roth MD, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al.. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation 2015;132:1667–1678. doi: 10.1161/CIRCULATIONAHA.114.008720 PubMed DOI
Zeitouni M, Sabouret P, Kerneis M, Silvain J, Collet JP, Bruckert E, et al.. 2019. ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations. Eur Heart J Cardiovasc Pharmacother. 2020;pvaa077. doi: 10.1093/ehjcvp/pvaa077 PubMed DOI
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al.. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111–118. Erratum in: Eur Heart J. 2020;41:4255. doi: 10.1093/eurheartj/ehz455 PubMed DOI
Pollin TI, Quartuccio M. What we know about diet, genes, and dyslipidemia: Is there potential for translation? Curr Nutr Rep. 2013;2:236–242. doi: 10.1007/s13668-013-0065-z PubMed DOI PMC
Cole CB, Nikpay M, McPherson R. Gene-environment interaction in dyslipidemia. Curr Opin Lipidol. 2015;26:133–138. doi: 10.1097/MOL.0000000000000160 PubMed DOI
Shkolnikov VM, Andreev EM, Tursun-Zade R, Leon DA. Patterns in the relationship between life expectancy and gross domestic product in Russia in 2005–15: a cross-sectional analysis. Lancet Public Health 2019;4:e181–e188. doi: 10.1016/S2468-2667(19)30036-2 PubMed DOI PMC
van Vliet P, Westendorp RG, van Heemst D, de Craen AJ, Oleksik AM. Cognitive decline precedes lite-life longitudinal changes in vascular risk factors. J Neurol Neurosurg Psychiatry 2010;81:1028–1032. doi: 10.1136/jnnp.2009.182519 PubMed DOI
Lutsey PL, Rasmussen-Torvik LJ, Pankow JS, Alonso A, Smolenski DJ, Tang W, et al.. Relation of lipid gene scores to longitudinal trends in lipid levels and incidence of abnormal lipid levels among individuals of European ancestry: the Atherosclerosis Risk in Communities (ARIC) study. Circ Cardiovasc Genet. 2012;5:73–80. doi: 10.1161/CIRCGENETICS.111.959619 PubMed DOI PMC
Upmeier E, Lavonius S, Heinonen P, Viitanen M, Isoaho H, Arve S, et al.. Longitudinal changes in serum lipids in older people the Turku elderly study 1991–2006. Age Ageing 2011;40:280–283. doi: 10.1093/ageing/afq180 PubMed DOI
Dayimu A, Wang C, Li J, Fan B, Ji X, Zhang T, et al.. Trajectories of lipids profile and incident cardiovascular disease risk: A longitudinal cohort study. J Am Heart Assoc. 2019;8:e013479. doi: 10.1161/JAHA.119.013479 PubMed DOI PMC
Duncan MS, Vasan RS, Vanessa X. Trajectories of blood lipid concentrations over the adult life course and risk of cardiovascular disease and all-cause mortality: Observations from the Framingham Study over 35 years. J Am Heart Assoc. 2019;8:e011433. doi: 10.1161/JAHA.118.011433 PubMed DOI PMC
Peasey A, Bobak M, Kubinova R, Malyutina S, Pajak A, Tamosiunas A, et al.. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health 2006;6:255. doi: 10.1186/1471-2458-6-255 PubMed DOI PMC
Peasey A, Bobak M, Malyutina S, Pajak A, Kubinova R, Pikhart H, et al.. Do lipids contribute to the lack of cardio-protective effect of binge drinking: alcohol consumption and lipids in three eastern European countries. Alcohol Alcohol. 2005;40:431–435. doi: 10.1093/alcalc/agh161 PubMed DOI
Nikitin YP, Makarenkova KV, Malyutina SK, Pajak A, Kubinova R, Peasey A, et al.. [Blood lipid parameters in populations of Russia, Poland and Czech Republic: The HAPIEE study]., Article in Russian. Kardiologiia 2015;55:34–39. doi: 10.18565/cardio.2015.5.34-39 PubMed DOI
Hu Y, Malyutina S, Pikhart H, Peasey A, Holmes MV, Hubacek J, et al.. The relationship between body mass index and 10-year trajectories of physical functioning in middle-aged and older Russians: prospective results of the Russian HAPIEE study. J Nutr Health Aging 2017;21:381–388. doi: 10.1007/s12603-016-0769-z PubMed DOI
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502. PubMed
Leckie G, Charlton C. runmlwin: a program to run the MLwiN multilevel modeling software from within Stata. J Stat Soft. 2012;52: doi: 10.18637/jss.v052.i11 DOI
Paige E, Barrett J, Pennells L, Sweeting M, Willeit P, Di Angelantonio E, et al.. Use of repeated blood pressure and cholesterol measurements to improve cardiovascular disease risk prediction: An individual-participant-data Meta-analysis. Am J Epidemiol. 2017;186:899–907. doi: 10.1093/aje/kwx149 PubMed DOI PMC
Cho IJ, Sung JM, Chang HJ, Chung N, Kim HC. Incremental value of repeated risk factor measurements for cardiovascular disease prediction in middle-aged Korean adults: Results from the NHIS-HEALS (National Health Insurance System-National Health Screening Cohort). Circ Cardiovasc Qual Outcomes 2017;10:pii: e004197. doi: 10.1161/CIRCOUTCOMES.117.004197 PubMed DOI
Ockene IS, Chiriboga DE, Stanek EJ 3rd, Harmatz MG, Nicolosi R, Saperia G, et al.. Seasonal variation in serum cholesterol levels: treatment implications and possible mechanisms. Arch Intern Med. 2004;164:863–870. doi: 10.1001/archinte.164.8.863 PubMed DOI
Reinikainen J, Laatikainen T, Karvanen J, Tolonen H. Lifetime cumulative risk factors predict cardiovascular disease mortality in a 50-year follow-up studying Finland. Int J Epidemiol. 2015;44:108–116. doi: 10.1093/ije/dyu235 PubMed DOI
Packard CJ, Weintraub WS, Laufs U. New metrics needed to visualize the long term impact of early LDL-C lowering on the cardiovascular disease trajectory. Vas Pharmacol. 2015;71:37–39. doi: 10.1016/j.vph.2015.03.008 PubMed DOI PMC
Ference BA, Bhatt DL, Catapano AL, Packard CJ, Graham I, Kaptoge S, et al.. Association of genetic variants related to combined exposure to lower low-density lipoproteins and lower systolic blood pressure with lifetime risk of cardiovascular disease. JAMA. 2019;322):1381–1391. doi: 10.1001/jama.2019.14120 PubMed DOI PMC
Lind L, Ingelsson M, Sundstrom J, Ȁrnlȫv J. Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomization findings. Open Heart. 2021;8:e001735. doi: 10.1136/openhrt-2021-001735 PubMed DOI PMC
Su X, Kong Y, Peng D. Evidence for changing lipid management strategy to focus on non-high density lipoprotein cholesterol. Lipids Health Dis. 2019;18:134. doi: 10.1186/s12944-019-1080-x PubMed DOI PMC
Eliasson M, Janlert U, Jansson JH Stegmayr B. Time trends in population cholesterol levels 1986–2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study. J Intern Med. 2006;260:551–559. doi: 10.1111/j.1365-2796.2006.01730.x PubMed DOI
Cífková R, Bruthans J, Wohlfahrt P, Krajčoviechová A, Šulc P, Jozífová M, et al.. 30-year trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post-MONICA, 1985–2016/17. Plos One 2020;15:e0232845. doi: 10.1371/journal.pone.0232845 PubMed DOI PMC
Liu J, Zeng FF, Liu ZM, Zhang CX, Ling WH, Chen YM. Effect of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studies. Lipids Health Dis. 2013;12:159. doi: 10.1186/1476-511X-12-159 PubMed DOI PMC
Pikhart H, Hubáček JA, Peasey A, Kubínová R, Bobák M. Association between fasting plasma triglycerides, all-cause and cardiovascular mortality in Czech population. Results from the HAPIEE study. Physiol Res. 2015;64 (Suppl 3):S355–S361. doi: 10.33549/physiolres.933179 PubMed DOI
Hubacek JA, Stanek V, Gebauerova M, Adamkova V, Lesauskaite V, Zaliaduonyte-Peksiene D, et al.. Traditional risk factors of acute coronary syndrome in four different male populations—total cholesterol value does not seem to be relevant risk factor. Physiol Res. 2017;66 (Suppl 1):S121–S128. doi: 10.33549/physiolres.933597 PubMed DOI
Tamosiunas A, Luksiene D, Baceviciene M, Bernotiene G, Radisauskas R, Malinauskiene V, et al.. Health factors and risk of all-cause, cardiovascular, and coronary heart disease mortality: findings from the MONICA and HAPIEE studies in Lithuania. PLoS One 2014;9:e114283. doi: 10.1371/journal.pone.0114283 PubMed DOI PMC
Stefler D, Bobak M. Does the consumption of fruits and vegetables differ between Eastern and Western European populations? Systematic review of cross-national studies. Arch Public Health 2015;73:29. doi: 10.1186/s13690-015-0078-8 PubMed DOI PMC
Stefler D, Pikhart H, Jankovic N, Kubinova R, Pajak A, Malyutina S, et al.. Healthy diet indicator and mortality in Eastern European populations: prospective evidence from the HAPIEE cohort. Eur J Clin Nutr. 2014;68:1346–1352. doi: 10.1038/ejcn.2014.134 PubMed DOI PMC
Abbott RD, Garrison RJ, Wilson PW, Epstein FH, Castelli WP, Feinleib M, et al.. Joint distribution of lipoprotein cholesterol classes. The Framingham study. Arteriosclerosis 1983;3:260–272. doi: 10.1161/01.atv.3.3.260 PubMed DOI
Swiger KJ, Martin SS, Blaha MJ, Toth PP, Nasir K, Michos ED, et al.. Narrowing sex differences in lipoprotein cholesterol subclasses following mid-life: the very large database of lipids (VLDL-10B). J Am Heart Assoc, 2014;3:e000851. doi: 10.1161/JAHA.114.000851 PubMed DOI PMC
Carroll MD, Kit BK, Lacher DA, Shero ST, Mussolino ME. Trends in lipids and lipoproteins in US adults, 1988–2010. JAMA 2012;308:1545–1554. doi: 10.1001/jama.2012.13260 PubMed DOI
Puri R, Nissen SE, Shao M, Elshazly MB, Kataoka Y, Kapadia SR, et al.. Non-HDL cholesterol and triglycerides: Implications for coronary atheroma progression and clinical events. Arterioscler Thromb Vasc Biol. 2016;36:2220–2228. doi: 10.1161/ATVBAHA.116.307601 PubMed DOI
Malyutina SK, Simonova GI, Nikitin YuP. The incidence of coronary heart disease and cardiovascular mortality in the urban Siberian population: Gender specific findings from the 10-year cohort study. In: Heart Disease: Environment, Stress and Gender. (Eds. Weidner G., Kopps M., Kristenson M.) NATO Science Series, Series I: Life and Behavioral Sciences. - 2000.—Vol. 327:p. 69–79.